Skip to main content
. 2015 Sep;100(9):1172–1179. doi: 10.3324/haematol.2015.125849

Figure 3.

Figure 3.

Kaplan-Meier estimates of overall survival (OS) and event-free survival (EFS). (A). OS for the entire cohort and treatment arm measured by Kaplan-Meier methodology. OS is defined as the date of randomization to date of last follow up or death. (B). EFS for the entire cohort and treatment arm measured by Kaplan-Meier methodology. EFS is defined as time from randomization to persistent AML after one cycle of induction therapy, relapse, death, or date of last follow up (censored).